Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,053 signal articles · 244 in last 24h · 119,495 total before filter · latest 1h ago
244last 24h
1496last 7d
250● bullish (7d)
157● bearish (7d)
205publishers
AllMacro287Earnings582M&A107Regulatory20Product13Analyst22
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Forget Palantir: This Enterprise Software Fortress Is a No-Brainer Buy
24/7 Wall St.57d agobullish
Forget Palantir: This Enterprise Software Fortress Is a No-Brainer Buy

Everyone is still piling into Palantir Technologies (NASDAQ:PLTR) after another blowout earnings report, with U.S. commercial revenue exploding 133% year over year and CEO Alex Karp bragging about a Rule of 40 score of 145%. But here’s what you should actually be watching. The Palantir Trade Is Already Priced for Three Perfect Years Palantir is ... Forget Palantir: This Enterprise Software Fortress Is a No-Brainer Buy

Investing.com57d agobullish
Morgan Stanley upgrades CDW on stronger AI-driven server demand

Investing.com -- Morgan Stanley upgraded CDW Corporation to Overweight and raised price targets across several IT hardware names, arguing that enterprise server demand is proving far more resilient than expected as companies accelerate investments in AI infrastructure and data center modernization.

3 Reasons CMCO is Risky and 1 Stock to Buy Instead
StockStory57d agobullish
3 Reasons CMCO is Risky and 1 Stock to Buy Instead

Over the past six months, Columbus McKinnon’s shares (currently trading at $14.54) have posted a disappointing 17.3% loss, well below the S&P 500’s 8.5% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
Zacks57d agobullish
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

3 Reasons SDRL is Risky and 1 Stock to Buy Instead
StockStory57d agobullish
3 Reasons SDRL is Risky and 1 Stock to Buy Instead

Over the past six months, Seadrill has been a great trade, beating the S&P 500 by 13%. Its stock price has climbed to $39.86, representing a healthy 21.6% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

UBS sees AI FOMO fuelling US share rally
Proactive57d agobullish
UBS sees AI FOMO fuelling US share rally

UBS has said US investors' fear of missing out on a bull market rally has been the key recent driver of market gains, particularly for artificial intelligence stocks. The wealth management arm of the Swiss bank pointed to clear signs of that anxiety among retail investors. It noted that a...

2 Reasons to Avoid DFIN and 1 Stock to Buy Instead
StockStory57d agobullish
2 Reasons to Avoid DFIN and 1 Stock to Buy Instead

Over the last six months, Donnelley Financial Solutions’s shares have sunk to $38.47, producing a disappointing 17% loss - a stark contrast to the S&P 500’s 8.5% gain. This may have investors wondering how to approach the situation.